PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING CANCER Russian patent published in 2014 - IPC A61K39/395 

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions provides a pharmaceutical composition containing an antibody or its fragment immunoresponsive to a polypeptide containing at least 7 adherent amino acids in the CD179b protein, which has been identified as a tumour-specific antigen protein specifically expressed on the tumour cell surface, as well as a method for treating and/or preventing cancer involving administering the declared composition.

EFFECT: group of invention enables the high efficiency identification of the tumour-specific antigen proteins specifically expressed on the tumour cell surface, and refers to using the protein-targeted antibodies as agents for treating and/or preventing cancer.

6 cl, 2 dwg, 5 ex